SEC Info - Immunic, Inc. - ‘8-K’ for 4/12/19

SEC Info℠

Home

Help

Please Sign In

Immunic, Inc. – ‘8-K’ for 4/12/19 – ‘EX-16.1’

On: Monday, 4/15/19, at 4:30pm ET · For: 4/12/19 · Accession #: 1193125-19-106593 · File #: 1-36201

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/15/19  Immunic, Inc.                     8-K:2,3,4,5 4/12/19    5:127K                                   Donnelley … Solutions/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     32K 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML     11K 
 3: EX-10.2     Material Contract                                   HTML     38K 
 5: EX-99.1     Miscellaneous Exhibit                               HTML     20K 
 4: EX-16.1     Letter re: Change in Certifying Accountant          HTML      5K

EX-16.1 — Letter re: Change in Certifying Accountant

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-16.1

Exhibit 16.1

LOGO

April 15, 2019

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We have read the statements made by Vital Therapies, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of Vital Therapies, Inc. dated April 12, 2019. We agree with the statements concerning our Firm contained therein.

Very truly yours,

/s/ PricewaterhouseCoopers LLP

San Diego, California

Dates Referenced Herein

This ‘8-K’ Filing	Date	Other Filings

Filed on:	4/15/19	None on these Dates
For Period End:	4/12/19
		List all Filings

↑Top

Filing Submission 0001193125-19-106593 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)